Cholestasis from glibenclamide
Marriott Díaz, E.; Miranda Baiochi, R.; Hernández-Guío, C.
Revista Espanola de Enfermedades Digestivas Organo Oficial de la Sociedad Espanola de Patologia Digestiva 77(6): 456-457
1990
ISSN/ISBN: 1130-0108 PMID: 2121195 Document Number: 365969
Document emailed within 1 workday
Related Documents
Gross, R.; Mion, F.; Paliard, P. 1993: Cholestasis induced by roxithromycin in a patient with a past history of pregnancy intrahepatic cholestasis Gastroenterologie Clinique et Biologique 17(2): 146-147Calvo, C.; Arroqui, I. 1984: Quantitative determination of lipoprotein-X (LP-X) in extrahepatic cholestasis and intrahepatic cholestasis Revista Medica de Chile 112(3): 233-237
Rupp, W.; Christ, O.; Fülberth, W. 1972: Studies on the bioavailability of glibenclamide Arzneimittel-Forschung 22(2): 471-473
Talseth, T.; Eika, C. 1978: Protracted glibenclamide induced hypoglycemia Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 98(19-21): 949-950
Devlin, J.G.; Manning, K.; Harty, J. 1971: Glibenclamide in the management of diabetes mellitus. i Journal of the Irish Medical Association 64(409): 197-199
Ziler, T.; Waldthaler, A.; Ermler, R.; Bottermann, P. 1975: Effect of gliquidone and glibenclamide following oral administration Münchener Medizinische Wochenschrift 117(36): 1423-1424
Ser, I. 1971: Clinical experience with glibenclamide, a new hypoglycemic agent Harefuah 81(8): 364-368
Annamala, P.T.; Augusti, K.T. 1980: Effects of glibenclamide on normal rabbits: a biochemical study Indian Journal of Experimental Biology 18(8): 847-849
Neugebauer, G.; Betzien, G.; Hrstka, V.; Kaufmann, B.; von Möllendorff, E.; Abshagen, U. 1985: Absolute bioavailability and bioequivalence of glibenclamide (Semi-Euglucon N) International Journal of Clinical Pharmacology Therapy and Toxicology 23(9): 453-460
Dankelman, J.; Van der Ploeg, C.P.; Spaan, J.A. 1994: Glibenclamide decelerates the responses of coronary regulation in the goat American Journal of Physiology 266(5 Pt 2): H1715-H1721
Palmieri, G.; Alkabes, M. 1977: Treatment of overweight diabetics with a combination of glibenclamide and phenformin La Clinica Terapeutica 81(6): 537-546
Hassan, M.A.; Sheikh Salem, M.; Sallam, E.; al-Hindawi, M.K. 1997: Preparation and characterization of a new polymorphic form and a solvate of glibenclamide Acta Pharmaceutica Hungarica 67(2-3): 81-88
Rostlapil, J.; Zrůstová, M. 1971: Case of regeneration of the islands of Langerhans in a diabetic, following the use of glibenclamide Vnitrni Lekarstvi 17(12): 1203-1206
Belloni, F.L.; Hintze, T.H. 1991: Glibenclamide attenuates adenosine-induced bradycardia and coronary vasodilatation American Journal of Physiology 261(3 Pt 2): H720-H727
Knick, B.; Thomas, L.; Vollmar, J.; Bauer, G. 1979: The effect of metipranolol on the carbohydrate metabolism in diabetics treated with glibenclamide Medizinische Klinik 74(9): 313-317
Bunnag, S.C.; Israsena, T.; Watananukul, P. 1972: Blood coagulation in maturity--onset diabetics before and after treatment with glibenclamide Journal of the Medical Association of Thailand 55(2): 80-86
Feldman, S.; Camus-Bablon, F. 1994: Experience and present status: glibenclamide (Daonil), a reference molecule Journees Annuelles de Diabetologie de l'Hotel-Dieu 1994: 283-294
Deĭneka, G.K.; Kharchenko, N.S.; Gusarova, E.S. 1976: Effect of glibenclamide on several indices of the cardiovascular system and carbohydrate balance Farmatsevtychnyi Zhurnal 6: 48-51
Burns, F.H. 1971: Glibenclamide--experience at Royal Prince Alfred Hospital 1967-70 Australian and New Zealand Journal of Medicine 1(Suppl 2): 67-71
Gervasini, A. 1974: Therapeutic activity of a glibenclamide-phenformin association in maturity-onset diabetes Minerva Medica 65(73): 3835-3842